| Title | Changing trends in the hospital management of unstable angina: a drug utilization analysis. | | Author(s) | Chandra KK, Malhotra S, Gupta M, Grover A, Sharma N, Pandhi P | | Institution | Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, India. | | Source | Int J Clin Pharmacol Ther 2004 Oct; 42(10):575-80. | | MeSH | Angina, Unstable
Antihypertensive Agents
Drug Utilization
Female
Fibrinolytic Agents
Hospitals
Humans
India
Male
Middle Aged
Prescriptions, Drug
Vasodilator Agents
| | Abstract | OBJECTIVE: The current study was designed to investigate drug utilization in the management of unstable angina in India and to examine the changing trends in the management of unstable angina over the past 4 years.
METHODS: We conducted a prescription survey to examine the use of antianginal drugs in patients with unstable angina in a tertiary care Indian hospital. The use of concurrent medications such as antidiabetic, antihypertensive and lipid-lowering agents was also examined. This study results were compared with a similar study done in this institute 4 years earlier.
RESULTS: A total of 159 consecutive prescriptions were evaluated. Aspirin (86%), nitroglycerin infusion (77%) and low-molecular weight heparins (93%) were the most frequently prescribed drugs. Enoxaparin accounted for 76% of the total LMWH use. One of the heparins was used by 92% of all patients, angiotensin-converting enzyme inhibitors (ACEIs) and beta-blockers by 70% and 67%, respectively. Lipid-lowering agents (57%), antidiabetic agents (16%) and antianxiety agents (33%), in addition to antianginals, were also frequently co-administered. Time trend analysis showed that the use of unfractionated heparin fell from 35% to 10% and the use of ACEIs and enoxaparin increased from 17% to 70% and from 51% to 71%, respectively.
CONCLUSIONS: The study showed that unfractionated heparin is less frequently used in the treatment of unstable angina than in the past and that ACEIs are preferred to calcium channel blockers. Enoxaparin remains the most commonly used low-molecular weight heparin for this indication. A variety of low-molecular weight heparins are available for therapy but comparative clinical trials of efficacy and pharmacoeconomic studies comparing the various LMWHs still need to be carried out. | | Language | eng | | Pub Type(s) | Comparative Study
Journal Article
| | PubMed ID | 15516028 |
|
